Roselabs Finance schedules EGM on Oct 9 to approve merger scheme

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Roselabs Finance schedules EGM on Oct 9, 2026, to approve merger scheme
  • NCLT ordered meeting on August 6, 2026, following merger proposal
  • E-voting opens Oct 6 and closes Oct 8, 2026
  • Intimation filed under SEBI Regulation 30 and Companies Act provisions
powered bylight_fuzz_icon
50096657

*this image is generated using AI for illustrative purposes only.

Roselabs Finance has scheduled an extraordinary general meeting for October 9, 2026, to seek shareholder approval for its proposed merger by absorption with National Standard (India) Limited and Lodha Developers Limited. The meeting follows an order from the National Company Law Tribunal dated August 6, 2026, directing the convening of the shareholder vote.

Meeting Details

The company will conduct the meeting via video conferencing or other audio-visual means. Shareholders can participate in remote e-voting starting October 6, 2026, at 9:00 am until October 8, 2026, at 5:00 pm. The cut-off date for e-voting eligibility is October 2, 2026.

Particulars Details
Meeting Date October 9, 2026
Time 10:00 am
Mode VC/OAVM
E-voting Start October 6, 2026, 9:00 am
E-voting End October 8, 2026, 5:00 pm

Regulatory Compliance

Roselabs Finance issued the intimation under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The notice includes the explanatory statement required under Section 230(3) read with Section 102 of the Companies Act, 2013. The company is circulating these documents electronically to all equity shareholders.

Shareholders can access the notice and annexures on the company’s website. Gunjan Taunk, Company Secretary and Compliance Officer, signed the disclosure filed with the BSE on September 4, 2026.

Historical Stock Returns for Roselabs Finance

1 Day5 Days1 Month6 Months1 Year5 Years
-5.00%-1.58%-5.00%+5.56%-25.93%-12.95%

What strategic synergies or financial benefits are Roselabs Finance, National Standard, and Lodha Developers expecting to realize from this three-way merger?

How might the proposed merger impact the valuation and stock performance of the involved entities in the months following shareholder approval?

Are there any potential regulatory hurdles or antitrust concerns that could delay the finalization of this merger after the October 2026 vote?

Roselabs Finance AGM passes all four resolutions with 100% support

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • All four ordinary resolutions passed with 100% support at the 32nd AGM
  • Total votes polled reached 83,60,068, representing 83.60% of outstanding shares
  • Promoter group voted 100% of their 74,24,670 share holding
  • Public non-institutional participation stood at 36.32%
  • Ms. Sanjyot Rangnekar and Mr. Raghava Reddy Balineni were re-appointed
powered bylight_fuzz_icon
49370127

*this image is generated using AI for illustrative purposes only.

Roselabs Finance shareholders approved all four ordinary resolutions at the 32nd Annual General Meeting held on August 27, 2026, through video conferencing. The meeting concluded with unanimous support for every agenda item.

The company reported a total of 83,60,068 votes polled out of 1 crore outstanding shares, representing an 83.60% participation rate. All resolutions received 100% affirmative votes from both promoter and public shareholders.

Key Resolutions Passed

The agenda included the adoption of audited financial statements for FY26, re-appointment of directors, and appointment of statutory auditors. The voting breakdown is detailed below:

Resolution Votes Polled Votes In Favour Result
Adoption of FY26 Financials 83,60,068 83,60,068 Passed
Re-appointment of Ms. Sanjyot Rangnekar 83,60,068 83,60,068 Passed
Appointment of Walker Chandiok & Co. LLP as Statutory Auditors 83,60,068 83,60,068 Passed
Re-appointment of Mr. Raghava Reddy Balineni as MD 83,60,068 83,60,068 Passed

Ms. Sanjyot Rangnekar, Chairperson, was re-appointed as a director retiring by rotation. Mr. Raghava Reddy Balineni was re-appointed as Managing Director for a period of five years. M/s Walker Chandiok & Co. LLP was appointed as the statutory auditors of the company.

What the Numbers Show

The voting data reveals a distinct concentration of shareholder engagement. Promoter and promoter group shareholders held 74,24,670 shares and voted 100% of their holdings. In contrast, public non-institutional shareholders held 25,75,330 shares but cast votes on only 9,35,398 shares, resulting in a 36.32% participation rate for this segment. This disparity highlights that while overall approval was unanimous, active voting participation was heavily driven by the promoter group.

Historical Stock Returns for Roselabs Finance

1 Day5 Days1 Month6 Months1 Year5 Years
-5.00%-1.58%-5.00%+5.56%-25.93%-12.95%

How might the re-appointment of Mr. Raghava Reddy Balineni as MD for a five-year term influence Roselabs Finance's strategic direction and growth trajectory?

What specific financial performance metrics from the adopted FY26 audited statements should investors monitor to assess the company's health post-AGM?

Given the low participation rate among public non-institutional shareholders, what measures might Roselabs Finance implement to improve retail investor engagement in future governance decisions?

More News on Roselabs Finance

1 Year Returns:-25.93%